About us
Назад
About us
History
Structure
Management
Manufacturing
Назад
Manufacturing
API & FDF Experimental Producton
Сustom chemistry services
Preclinical research services
Biotechnological Producton (BioIntegrator)
Portfolio
Назад
Portfolio
BioIntegrator
Viriom
Chromis
Aviron, Avivir
CardioSystemPharma
NewVac
Avineuro
Infrastructure
Назад
Infrastructure
ChemRar Research and Development Institute
Chemical Diversity Research Institute
API-Technology
Biotechnological production (BioIntegrator)
Technopark management
News
Contacts
RUS
ENG
+7 (495) 925-30-74
Home
>>
Gallery
>>
2014
2014
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
СМОТРЕТЬ
Company news
07.05.2023
Representatives of ChemRar Group made a business trip to Morocco
29.04.2023
Representatives of ChemRar Group visited Ethiopia to take part in the investment forum
17.01.2023
Scientific review: Favipiravir as a treatment for RNA viruses, including COVID-19
27.12.2021
ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron
17.06.2021
Avifavir® for the treatment of COVID-19 is rated among Russia’s TOP 100 Inventions
All news
Ajax Call Form
Loading...
Close
Search for:
Search Button
×
